Long-term outcomes of the Ovation Stent Graft System investigational device exemption trial for endovascular abdominal aortic aneurysm repair.
Andrew Barleben, Asma Mathlouthi, Manish Mehta...
https://pubmed.ncbi.nlm.nih.gov/32249041/Actively Recruiting
Led by Gianmarco de Donato · Updated on 2023-07-20
300
Participants Needed
2
Research Sites
52 weeks
Total Duration
Researchers are evaluating the outcomes of treating patients with elective Abdominal Aortic Aneurysm AAA using the ALTO stent graft device from Endologix Inc. This observational study focuses on assessing the results during and after the surgery, including early and late outcomes, in a multicenter experience. The study builds on decades of technological advancements in endovascular aneurysm repair, particularly highlighting the innovative sealing mechanism of the ALTO device. The ALTO device implantation involves placing an aorto-bisiliac endograft to exclude the aneurysm, using a low-profile platform designed for challenging anatomies. All eligible patients undergoing elective endovascular aneurysm repair EVAR with the ALTO device will be included based on their medical needs, anatomical suitability, and physician expertise. The study will collect data during the procedure and at set follow-up times to evaluate technical and clinical success. Participants will be monitored through follow-up visits lasting up to five years, during which researchers will assess technical and clinical success at 90 days, one year, and five years after treatment. Additional measures include operative time, radiation exposure, contrast medium usage immediately after the procedure, and aneurysm shrinkage at one and five years. Patients are expected to comply with follow-up evaluations to help researchers understand the devices performance and patient outcomes over time.
CONDITIONS
ALTo endogrAft Italian Registry
G
Gianmarco de Donato, MD, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Gianmarco de Donato
Lead Sponsor
University of Roma La Sapienza
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Day of procedure
Participants undergo the implantation of the ALTO endograft device to repair the abdominal aortic aneurysm.
1 procedure visit (in-person)
Duration - Up to 5 years
Participants are monitored to evaluate technical and clinical success, aneurysm shrinkage, and other outcomes after the ALTO endograft implantation.
Follow-up visits at 90 days, 1 year, and annually up to 5 years
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Andrew Barleben, Asma Mathlouthi, Manish Mehta...
https://pubmed.ncbi.nlm.nih.gov/32249041/Gianmarco de Donato, Edoardo Pasqui, Mariagnese Mele...
https://pubmed.ncbi.nlm.nih.gov/31676183/Gianmarco de Donato, Edoardo Pasqui, Claudia Panzano...
https://pubmed.ncbi.nlm.nih.gov/33917214/Pasqualino Sirignano, Wassim Mansour, Laura Capoccia...
https://pubmed.ncbi.nlm.nih.gov/31793884/Gianmarco de Donato, Edoardo Pasqui, Claudia Panzano...
https://pubmed.ncbi.nlm.nih.gov/34950916/Gianmarco de Donato, Edoardo Pasqui, Pasqualino Sirignano...
https://pubmed.ncbi.nlm.nih.gov/35816378/Andrew Holden, Sean Lyden
https://pubmed.ncbi.nlm.nih.gov/32025596/G de Donato, F Setacci, P Sirignano...
https://pubmed.ncbi.nlm.nih.gov/24356044/Gianmarco de Donato
Lead Sponsor
University of Roma La Sapienza
Collaborating Sponsor